Inventors:
Max P. Oeschger - Silver Spring MD
Anne M. Hooke - Annandale VA
Joseph A. Bellanti - Bethesda MD
Assignee:
Research Corporation - New York NY
International Classification:
A61K 39102
A61K 3902
C12N 1500
C12N 120
Abstract:
The present invention relates to a vaccine composition for the prevention of infectious diseases comprising an immunogenically-effective amount of a genetically attenuated and stable avirulent bacterial strain derived from a virulent bacterial strain by introducing into said virulent strain by genetic transfer and recombination at least two mutations of the same phenotype which renders said virulent strain avirulent, while permitting said avirulent strain to retain immunogenicity, together with an inert pharmacologically acceptable carrier. It also relates to a method for preparing the vaccine.